Efficacy of aprepitant among patients aged 65 and over receiving moderately to highly emetogenic chemotherapy: A meta-analysis of unpublished data from previously published studies-Reference-Cited by-同舟云学术

Efficacy of aprepitant among patients aged 65 and over receiving moderately to highly emetogenic chemotherapy: A meta-analysis of unpublished data from previously published studies

Published:2013-01 Issue:1 Volume:4 Page:78-83
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Chapell Richard,Aapro Matti S.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference14 articles.

1. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

2. Addition of neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting, results from a randomized, double-blind, placebo-controlled trial in Latin America;Poli-Bigelli;Cancer,2003

3. Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment;Schmoll;Ann Oncol,2006

4. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy;Warr;J Clin Oncol,2005

5. Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase ΙΙΙ trials of aprepitant in patients receiving cisplatin-based chemotherapy;Hesketh;Support Care Cancer,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes;Drugs & Aging;2021-12-09

2. Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting;Medicine;2020-08-14

3. Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients;Clinical and Translational Oncology;2019-06-25

4. An Analysis of the Inclusion of Medications Considered Potentially Inappropriate in Older Adults in Chemotherapy Templates for Hematologic Malignancies: One Recommendation for All?;Drugs & Aging;2018-03-27

5. Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy;Journal of Pain and Symptom Management;2018-03